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Abstract. Microfluidics are emerging as a promising technology for
miniaturizing biological assays for applications in diagnostics and
research in life sciences because they enable the parallel analysis
of multiple analytes with economy of samples and in short time.
We have previously developed microfluidic networks for surface im-
munoassays where antibodies that are immobilized on one wall of
a microchannel capture analytes flowing in the microchannel. This
technology is capable of detecting analytes with picomolar sensitivity
and from sub-microliter volume of sample within 45 min. This pa-
per presents the theoretical modeling of these immunoassays where
a finite difference algorithm is applied to delineate the role of the
transport of analyte molecules in the microchannel (convection and
diffusion), the kinetics of binding between the analyte and the cap-
ture antibodies, and the surface density of the capture antibody on
the assay. The model shows that assays can be greatly optimized by
varying the flow velocity of the solution of analyte in the microchan-
nels. The model also shows how much the analyte-antibody binding
constant and the surface density of the capture antibodies influence
the performance of the assay. We then derive strategies to optimize
assays toward maximal sensitivity, minimal sample volume require-
ment or fast performance, which we think will allow further devel-
opment of microfluidic networks for immunoassay applications.
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1. Introduction
Microfluidics and biochips, which are derived from micro-
fabrication techniques, are emerging as powerful bioana-
lytical platforms (Tay, 2002; Ekins, 1998). Microfluidics
in particular, have the potential to detect multiple analytes
in a small volume of sample and can integrate multiple
functionalities for the processing of samples and the gener-
ation and acquisition of signals (Manz and Becker, 1998).
For these reasons, microfluidic devices are developed and
used for detecting disease markers and screening drug can-
didates as well as for antibody characterization (Nguyen
and Wereley, 2002). Different methods can be employed
to move liquids in microfluidics, such as pressure-driven
flow, electro-osmosis, or acceleration. Ideal microfluidics
are simple to utilize, reliable, fast, sensitive, versatile, and
cheap. One of the simplest approaches for producing flow
in capillaries is to use capillary forces. Capillary-driven
flow requires no peripheral equipment, and this concept
is used for portable immunodiagnostic tests (Apple et al.,
1999).
We are interested in developing capillary-driven mi-
crofluidic chips for diagnostic and bioanalytical applica-
tions in which fluorescence surface immunoassays are per-
formed in the microchannels of the chip, samples of one
microliter in volume or less are used, multiple analytes
are detected, and sensitivities down to 1 pM concentra-
tion of analytes can be achieved. An important step in
developing these devices was to employ a hydrophobic
elastomeric substrate for the assay and covering the elas-
tomer with a Si microfabricated element having a plurality
of microchannels (Bernard et al., 2001b). The assay takes
place on the areas of the elastomer that are exposed to
the microchannels. Each microchannel starts with a load-
ing pad and ends with a capillary pump (Juncker et al.,
2002). The capillary pressure along the flow path is en-
coded to secure the unidirectional filling of the liquid from
the loading pad to the capillary pump. Therefore, assays
are done by loading the necessary reagents (e.g. capture
antibody and detection antibody) and samples in the cor-
rect sequence in each loading pad. The assay conditions in
adjacent microchannels can be varied independently be-
cause the elastomer seals the microchannels efficiently.
This concept was recently exemplified by detecting TNF-
α in 0.6 µL volume of cell culture supernatant with 1 pM
sensitivity, and up to 170 test sites were made on a 1 mm2
area of the elastomer (Cesaro-Tadic et al., 2004). This con-
cept was also qualitatively applied to detect disease mark-
ers such as C-reactive protein (Wolf et al., 2004). Because
clinically relevant analyte concentrations are often spread
over a wide range from micromolar to picomolar concen-
trations, optimizing the microfluidic devices in terms of
covering a large dynamic range for the measurements is
important. At the same time, a microfluidic device should
also be suited to handle very small concentrations and if
possible minute volumes of analyte.
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We are interested in examining these previous results
analytically to identify the predominant assay parameters
and to derive optimization strategies for performing as-
says with such microfluidics for having optimal sensitiv-
ity, minimal sample requirement, or fastest possible times
to results.
Like other computational studies on the kinetics of
antigen binding in microchannels (Vijayendran et al.,
1999; Myszka et al., 1998; Edwards, 1999; Edwards
et al., 1999; Jenkins et al., 2004), our computational
model of fluid dynamics includes convection, diffusion
and receptor-ligand kinetics (Sapsford et al., 2001; Balgi
et al., 1995) of capillary-flow-driven microfluidic channels
and was implemented using a finite difference approach
(Griebel et al., 1995). Thereby, we solved the steady-state
uncompressed Navier-Stokes equation, combined with a
convection-diffusion model and a fluid-wall interaction
model which we describe below.
2. Methods
2.1. Microfluidic networks used in the analyses
Our model is implemented to describe the binding of an
antigen to a surface-immobilized capture antibody in a
microchannel, Figure 1, and is based on the geometri-
cal characteristics of microfluidic networks that we used
previously (Cesaro-Tadic et al., 2004). The microfluidic
networks had several independent microchannels, and we
therefore only need to consider one microchannel. Each
microfluidic channel is 20 µm deep, 30 µm wide and 1 mm
long. In typical experiments, the capture antibodies are
present in the second half of the channel, and the analytes
cannot be lost by sticking to the walls elsewhere than at the
capture sites because the walls are treated to be protein-
repellent (Prime and Whitesides, 1991). The capture area
is covered by individual capture antibody molecules with
Fig. 1. Configuration of a surface immunoassay in a microfluidic
channel. The liquid enters the channel at the inlet on the left-hand side
and flows through the channel under laminar conditions with a
parabolic flow profile. The flowing analyte solution contains molecules
which are transported in the channel. The molecules are allowed to
diffuse perpendicularly to the flow direction and can be captured by the
capture antibodies. Wall elements not covered with capture antibodies
are protected against unspecific binding, which in the simulation is
regarded as perfect.
a given surface density. We define the “feature area” as the
total capture area divided by the number of active capture
antibodies. If all capture antibodies were properly oriented
and able to bind two antigens each, the feature area would
be equal to half the footprint of a capture antibody. In
practice, only a fraction of the capture antibodies might
be functional and we will therefore explore the influence
of the feature area on the assays.
The analyte solution flows into the microchannel at
constant flow velocity and flow rate. The flow of an aque-
ous solution inside a small channel is typically laminar
(Reynolds number  1) and has a parabolic flow profile.
The analyte molecules are transported by convection along
the flow direction and in addition are free to diffuse. Each
time an analyte molecule reaches a capture site, a stan-
dard ligand-receptor binding model is applied to define
whether capture occurs. Both the association and disso-
ciation events are modeled. The binding kinetics as well
as the convection-diffusion model are described in more
detail in the next section.
In the model, we define the analyte exploitation as the
ratio between the number of captured analyte molecules
and the total number of analyte molecules that were
present in a given volume of sample that passed over the
capture zone. An assay where all analyte molecules would
flow in the microchannel without being captured would
have an analyte exploitation of zero and would generate
no signal. Inversely, an ideal assay would have an ana-
lyte exploitation of one. The available volume of analyte
solution is considered to be unlimited except when the
simulation is used to study the exploitation of analyte.
2.2. Models
The flow of a liquid in a region over time t is characterized
by a velocity vector field u, a pressure p and a density ρ.
For laminar, incompressible and viscous fluids the density
is constant. The flow is described by the Navier-Stokes
partial differential equation system
∂
∂t
u + (u · grad)u + grad p = 1
Re
u + g (1)
div u = 0 (2)
in dimensionless form with the Reynolds number Re and
external forces g. External forces such as gravity can be
neglected in such miniaturized systems. For Re  2100,
flow is considered to be laminar and has a characteristic
parabolic flow profile with zero flow velocity at the chan-
nel walls and peak flow velocity in the channel center.
Here, Re is ∼0.07 for the maximum flow rates consid-
ered.
The bulk concentration C of a solute in a given solution
is described by the Convection-Diffusion equation of the




+ u · grad C = DC + (t, x, y, C) (3)
with a diffusion coefficient D, a source term  and the
identical velocity vector field u given in equation (1).
We have applied the Stokes-Einstein-relation D = kT6πηRh ,
with the hydrodynamic radius Rh, the analyte viscosity η
and the Boltzmann constant k to estimate the diffusion co-
efficient D of the analyte molecule to D = 10−6 cm2s−1
which we used for all further calculations and which cor-
responds to the literature (Metsa¨muuronen et al., 2002)
where comparable values for small molecules such as
TNF-α are reported. The analyte viscosity was set to a
high plasma viscosity (Koenig et al., 1998) of 2 mPa s.
The association and the dissociation from the capture
site are described by the rate coefficients k, the analyte
concentration C and the density of free binding sites
(max − t) on the surface, using an ordinary differen-
tial equation of the form,
dt
dt
= kon C (max − t) − koff t (4)
for monovalent receptors and ligands. kon is the rate con-
stant for association, koff is the rate constant for disso-
ciation, C is the concentration of free molecules in the
fluid, t is the surface density at time t . max is the max-
imum surface density of molecules calculated from the
feature area of the individual capture molecules and is
assumed to be constant over time. In this simulation we
generally used 106 M−1 s−1 for kon and 10−3 s−1 for koff
(Santora et al., 2001), but in some case these constants
were modified.
The set of equations (1)–(4) is used to implement the
model describing the capture of an analyte by a surface-
immobilized capture site in a microfluidic channel. This
model uses the finite difference approach to calculate the
influences of the key parameters on the capture of ana-
lyte. The model is detailed in the Supplementary Infor-
mation, Part A, and validated in Part B by comparing
results from the simulation with analytical results when
the equations could be solved analytically. Equation (4) in
particular can be solved analytically for a constant analyte
concentration:
t = kon max Ckon C + koff
(
1 − e−(kon C+koff) t). (5)
The maximum binding density ˆbound of analyte on the
capture area depends only on the analyte concentration and
the binding constants kon and koff which are also known
as the equilibrium constant K :








The combination of equations (1) to (4) allows the study
of the influence of flow rate, analyte bulk concentration,
capture-site surface density and binding-rate coefficients
on the binding kinetics. Experimentally, captured analytes
might be detected directly using surface-sensitive tech-
niques or by binding them with fluorescently-labeled de-
tection antibodies. We do not need to take the binding
between captured analytes and detection antibodies into
account because this step is generally not limiting in im-
munoassays: a high concentration of detection antibodies
can be used to ensure fast completion of this binding re-
action, for example. First, we need to determine when the
capture reaction is reaction-limited or transport-limited.
3.1. Reaction-limited versus transport-limited kinetics
of capture
One of the key parameters that determine whether the ki-
netics of capture of analyte is reaction-limited or transport-
limited is the velocity of the analyte solution in the mi-
crochannel. The capture of the analyte is reaction-limited
if the number of molecules binding to the capture site per
unit of time remains similar for different flow velocities.
In contrast, the capture of the analyte is transport-limited
if the number of analyte molecules binding per unit of
time is sensitive to the flow velocity of the sample in the
microchannel. The analyte exploitation is represented in
Figure 2 as a function of the flow velocity. It increases
with decreasing flow velocity because insufficient mass
transport increases the reaction time for capture. For ve-
locities above 0.5 mm s−1, corresponding to flow rates
higher than 18 nL min−1 for the channels used in pre-
vious experiments, a system with a binding constant K
of 109 M−1 and a feature area of 1500 nm2 is reaction-
limited: the residency time of the analytes on the cap-
ture area is short and the analyte exploitation therefore is
small (∼5%). At lower flow rates, the analyte exploita-
tion increases but the binding reaction becomes transport-
limited because lower volumes of analyte solution are
available at the capture area per unit of time and thus
fewer molecules have a chance to be captured per unit of
time. A flow velocity of 0.7 mm s−1 was used in previ-
ous work (Cesaro-Tadic et al., 2004), and we suggest that
these experiments were performed in the reaction-limited
regime. We consider this flow velocity as well as lower
flow velocities in the remainder of the paper to encompass
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Fig. 2. Calculated mean analyte exploitation as a function of the flow
velocity in the first five minutes of the incubation time with 1 pM
analyte concentration. Adjusting the flow velocity (and flow rate)
affects the exploitation of the analyte molecules in a sample and is
therefore useful to minimize the absolute volume of analyte required for
saturation of the capture sites. The line is provided as a guide to the
eye. A binding constant of 109 M−1, analyte concentration of 1 pM and
a feature area of 1500 nm2 were selected here.
the different regimes. We specifically choose a flow ve-
locity of 0.07 mm s−1, where transport limitation already
occurs, and a flow velocity of 0.007 mm s−1, where the
capture according to Figure 2 falls in the transport-limited
regime. In this latter case, longer incubation times are
necessary to reach an equivalent signal intensity to the
reaction-limited case. In contrast to the transport-limited
case, the molecules in the sample volume are used more
efficiently.
We investigate the influence of the flow velocity and
the feature area on the number of analytes captured per
unit area, Figure 3. Capture antibodies that are passively
adsorbed on a hydrophobic surface have a footprint of
∼150 nm2 (Delamarche, 2004; Amzel and Poljak, 1979)
and it has been suggested that for this mode of deposi-
tion ∼10% of the antibodies might be correctly oriented
and preserved for capturing one antigen from solution
(Wild, 2001), which here would correspond to a feature
area of 1500 nm2. Using oriented antibodies and advanced
surface-immobilization strategies, the feature area can be
decreased. We consider for this reason a scenario where
each capture antibody has a chance to bind one antigen
(feature area of 150 nm2). The model developed here can
also be applied to situations with very different feature
areas, microchannel dimensions, binding constants, and
flow velocities.
Figure 3 shows how many analyte molecules are cap-
tured per unit area as a function of time for feature areas of
Fig. 3. Binding of analytes in solution to surface-immobilized
antibodies as a function of time and for a concentration of analyte of
1 nM (a, b) and 1 pM (c, d), and for a feature area of 1500 nm2 (a, c)
and 150 nm2 (b, d). This binding reaction corresponds to the capture
step of a surface immunoassay and takes place in a microchannel as
shown in Figure 1. The binding reaction is more sensitive to mass
transport limitations for the smaller feature areas (b and d) as well as
for lower analyte concentrations (c and d). A hypothetical
analyte-antibody binding constant of K = 109 M−1 was chosen for
these analyzes.
1500 and 150 nm2, various flow rates, and analyte concen-
trations of 1 nM and 1 pM. We selected 1 nM for the an-
alyte concentration because it corresponds to immunoas-
says that are relatively sensitive and used for many clinical
applications (Wild, 2001). A concentration of 1 pM rep-
resents a practical limit in sensitivity for immunoassays
and we want to use the model developed here to optimize
assays done using microfluidics for this analyte concen-
tration. Figure 3(a) and (b) show that, as expected, the
maximum surface density of captured analyte is inversely
proportional to the feature area, but also that the kinet-
ics of capture is affected by the feature area. For a larger
feature area (1500 nm2), it is less important to keep the
flow velocity high enough to repopulate the microchannel
with new analytes because the assay is reaction-limited.
This explains the similar outcomes of assays done using
flow velocities of 0.7 and 0.07 mm s−1. The binding re-
action becomes transport-limited for a flow velocity of
0.007 mm s−1, as visible in Figure 3(a). The graphs in
Figure 3(b) indicate that capture zones having a smaller
feature area exploit the solution from analyte faster than
those with a larger feature area. As a consequence, the
flow rate has a larger influence on the binding kinetics in
the case of smaller feature areas.
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The surface density of captured analytes decreases
dramatically when analytes are at 1 pM concentration,
Figure 3(c) and (d), which is dictated by the equilibrium
constant K . The binding reaction is slower than at 1 nM
in all cases, and the flow velocity as well as the feature
area affect the capture reaction in a similar way as at the
higher concentration.
3.2. Linear binding saturation curves at very low flow
velocities
Biological assays that need a long time to reach equi-
librium might have to be stopped early for convenience.
The graphs in Figure 3(a) and (b) show that saturation in
binding is nearly reached within 1000 s for a flow veloc-
ity of 0.7 mm s−1. The binding reactions for lower flow
velocities are much slower and show a linear behavior.
Although assays done under these conditions yield small
signals, they can be conveniently stopped at any point
in time, because uncertainties on the incubation time give
small errors on the signal. The model predicts that an assay
with 1500 nm2 feature area, 1 nM analyte concentration,
and 0.007 mm s−1 flow velocity has a relative error of
only ±4% when the incubation time is 300 ± 15 s. Inter-
estingly, such an assay leads to having 52 ± 2 captured
antigen per µm2, which after the binding of detection anti-
bodies should correspond to a signal well above the limit
of detection of conventional fluorescence scanners. The
model suggests that assays done with a 1 nM analyte con-
centration and different conditions have a similar relative
error when they are stopped after an incubation time of
300 ± 15 s. The graphs in Figure 3(c) and (d) reveal a
similar linear evolution of the signal with time for a 1 pM
analyte concentration. However, stopping the assay after
an arbitrarily short time for this lower analyte concentra-
tion is unlikely to be practical because of the much lower
surface density of captured analyte after 300 s. Long in-
cubation times are therefore crucial for assays with 1 pM
analyte concentration.
3.3. Influence of the feature area on the binding
kinetics
The density of active capture sites in surface immunoas-
says usually plays an important role in defining the max-
imum number of analyte molecules that can be captured
and therefore the maximum signal surface density that
can be reached. Preventing the denaturation of capture
antibodies during and after their deposition is therefore
important, and methods to orient antibodies so as to have
their epitope-binding part exposed at the surface-liquid in-
terface are sometimes employed. As explained above, we
based most of our modeling on feature areas of 1500 and
150 nm2, but now also investigate the role of the feature
area on the efficiency of the assay for 1 nM and 1 pM
Fig. 4. Efficiency of the capture of analyte molecules flowing at
various velocities in a microchannel as shown in Figure 1 as a function
of feature area and analyte concentration and for the first 5 min of the
assay. The ratio between analyte molecules flowing in the microchannel
and analyte molecules captured defines the analyte exploitation (a, c)
and the resulting density of analyte molecules captured on the surface
(b, d). The lines are provided as guides to the eye.
analyte concentration in more detail, Figure 4. We are
in particular interested in learning how the feature area
affects assays that have critical requirements such as uti-
lizing a very small amount of sample or being fast. We
therefore modeled the analyte exploitation for 5-min-long
assays using the same flow rates as before. As expected,
all graphs in Figure 4 show that the surface-density of
captured analytes increases with the inverse of the fea-
ture area so that the exploitation of analyte is maximal
with a feature area of 150 nm2. The capture and analyte
exploitation are particularly sensitive to the feature area
for flow velocities ≤ 0.07 mm s−1. The binding constants
kon and koff in equation (5) enforce the same time to equi-
librium for different surface densities of the capture area:
the number of capture events per unit of time is larger for
surfaces having a higher density of capture sites but the
maximum number of capture events is also proportionally
larger on these surfaces. As an example, an assay where
the feature area is 150 nm2 (first data points) is able to
capture ∼20% of the analyte molecules when the analyte
solution has a concentration of 1 nM and a flow velocity
of 0.7 mm s−1, Figure 4(a). This corresponds to an ana-
lyte exploitation of 20%. The analyte exploitation falls off
dramatically if the feature area is ≥1500 nm2. Reducing
the flow velocity will, however, increase the analyte ex-
ploitation significantly. The analyte exploitation is ∼86%
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when the feature area is 1500 nm2 (second data points)
and the flow velocity 0.007 mm s−1, for example.
The signal in the assay is proportional to the surface
density of captured analytes, and we therefore need to con-
sider what the effect of the feature area on the number of
analytes captured per unit area is, Figure 4(b). For feature
areas ≤1500 nm2, the density of captured molecules is
sensitive to the flow velocity and maximum for a velocity
of 0.7 mm s−1. We learned from Figure 4(b) that for these
conditions the analyte exploitation is poor, but the over-
all number of analyte captured is the highest. The capture
step of the assay here is clearly transport-limited. For fea-
ture areas ≥7500 nm2, the number of captured molecules
is small and not sensitive to the flow velocity. Compar-
ing the signals obtained for different flow velocities in the
transport-limited regime, a slow velocity of 0.007 mm s−1
gives a very small signal compared with that for a velocity
of 0.07 or 0.7 mm s−1. Assays done with an analyte con-
centration of 1 pM exhibit a similar behavior as those with
1 nM analyte concentration, Figure 4(c) and (d), except
that the density of captured molecules is always ∼1000
times smaller.
We have so far analyzed the performance of the assays
done in a microchannel for two key analyte concentra-
tions, and will next explore in more detail how the analyte
concentration affects the analyte exploitation, the density
of analytes captured on the surface, and the time needed
to reach equilibrium. We will also evaluate the influence
of the binding constant on the assay.
3.4. Effect of the analyte concentration on the analyte
exploitation
Both the analyte concentration and the binding constant
K determine the maximum density of analytes captured
on the surface at equilibrium. Equation (6) shows that a
maximum of 0.1% of the capture sites can bind an ana-
lyte at equilibrium when the analyte concentration is 1 pM
and the binding constant 109 M−1. This ratio increases to
50% for an analyte concentration of 1 nM. We take an
arbitrary duration of 5 min for the capture step, flow ve-
locities of 0.7, 0.07 and 0.007 mm s−1, and a 1500 nm2
feature area to investigate how the analyte exploitation
and the density of analytes captured on the surface vary
with the concentration, Figure 5. At analyte concentra-
tions ≤1 nM, the analyte exploitation is nearly invariant
with the concentration but is strongly influenced by the
flow velocity, as already discussed in Figure 2. This situa-
tion changes as soon as the analyte concentration becomes
larger than K . The analyte exploitation is an important cri-
terion for optimizing the assay when the total number of
analyte molecules in a sample is strongly limited, whereas
it becomes unimportant for high analyte concentration,
Figure 5. Five minutes suffice to have nearly all capture
Fig. 5. Mean analyte exploitation and surface density of captured
analytes resulting from a 5-min-long assay for various flow velocities
and analyte concentrations. The binding constant chosen here was
K = 109 M−1. The lines are provided as guides to the eye.
sites bound to an analyte when the analyte concentration
is ∼10 times larger than the equilibrium constant. Below
this concentration value, the surface density of captured
molecules diminishes strongly with the concentration of
analyte, as expected from equation (5). It becomes help-
ful in this case to employ a flow velocity ≥0.07 mm s−1
to minimize transport limitation. Importantly, the model
predicts that there will only be ∼0.16 captured analyte
per µm2 for a 5-min-long assay using a flow velocity of
0.7 mm s−1 and an initial analyte concentration of 1 pM.
Assays for such a low analyte concentration must be longer
and if possible should have a smaller flow velocity. Fig-
ure 3(d) showed that a sensitivity of 1 pM can be achieved
using an incubation time of ∼2500 s for the capture, which
is consistent with previous experimental work (Cesaro-
Tadic et al., 2004).
We now evaluate how strongly high concentrations
of analyte affect the time needed to saturate the capture
sites, Figure 6. We know from Figure 5 that saturation
of the capture sites can be reached for analyte concen-
trations ≥10 nM. With analyte concentrations ≥100 nM,
the capture sites are saturated within a few seconds. An
assay to detect an analyte at 100 nM concentration, us-
ing a 1500 nm2 feature area and a flow velocity of 0.7–
0.07 mm s−1, leads to a maximum signal after 45 s, ac-
cording to our model. This illustrates well the advantage
of miniaturizing assays using a microfluidic system. It
is preferable to reach equilibrium when the analyte con-
centration is high, as otherwise variations in the capture
duration render the assay imprecise. Conventional assays
prevent signal saturation and imprecision due to variations
of the incubation time by using a dilution series of the
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Fig. 6. Time to complete saturation of the capture sites as function of
analyte concentration. At concentrations ≤1 µM, time to equilibrium
can be increased by reducing the flow velocity and the feature area. For
analyte concentrations above 10 µM, the capture sites are saturated in
less than 1 s. The lines are provided as guides to the eye.
sample. The model shows a relative insensitivity of the
assay to the flow velocity for concentrations ≥1 µM. The
assays are in this case clearly reaction-limited.
3.5. Influence of the binding constant on the binding
kinetics
The binding constant K between the antigen and the cap-
ture antibody plays an important role on the maximum
surface density of analyte molecules that can be cap-
tured at equilibrium. We have seen above that the assay
is very sensitive to the analyte concentration when the
concentration falls below K . As we study the time re-
sponse of the binding, we need to distinguish the different
influences of the association and dissociation constants.
The key factors giving an antibody high or low affinity
are the association constant kon and the dissociation con-
stant koff. The influence of K was therefore investigated
for a 5-min-long capture step by setting kon from 104 to
108 M−1 s−1 while keeping koff unchanged and vice versa.
Figure 7(a) shows that the analyte exploitation increases
toward 100% with increasing kon, and the effect of kon
on the analyte exploitation convolves with the flow rate.
A significant analyte exploitation can be observed even
for a high flow velocity of 0.7 mm s−1 provided that kon
is very high (108 M−1s−1). Figure 7(b) shows that when
koff is varied and K < 109 M−1, the analyte exploita-
tion is limited because having koff > 0.001 s−1 results
in relatively high dissociation rates. For K ≥ 109 M−1
the association constant dominates the binding reaction,
and the analyte exploitation is only sensitive to the flow
velocity.
Fig. 7. Mean exploitation of analyte volume as function of the binding
constant in the first 5 min of the reaction. An increasing association
constant kon (a) results in increased exploitation of analyte volume,
whereas modification of the dissociation rate koff (b) affects the
exploitation of a 1 pM analyte only for K < 109 M−1 using a feature
area of 1500 nm2. The lines are provided as guides to the eye.
3.6. Comprehensive assay optimizations
The detailed model developed above enables us to propose
several strategies to optimize surface assays in which cap-
ture antibodies are present on one wall of a microchannel
and analytes have a concentration of only 1 pM. We keep
the geometry of the microchannel (30 × 20 µm2 in cross
section), the capture area (500 µm in length), and the bind-
ing constant K at 109 M−1 (kon = 106 M−1s−1 and koff =
10−3 s−1) the same as in the previous sections. In the fol-
lowing discussion we consider that the minimum surface
density of captured molecules that can be detected using
a conventional fluorescence scanner is ∼0.5 analyte per
µm2 (Genetix, 2004). The remaining parameters influenc-
ing the capture step are the flow velocity (or flow rate), the
feature area and the time for the capture step, all of which
are varied in the next simulations. On a practical level, the
flow rate can be changed by varying the evaporation rate
of filled capillary pumps or by changing the depth of the
channels.
3.6.1. Optimizing assays for fast measurement. We
are interested in exploring how fast a sensitive (analyte
concentration ≤1 nM) sandwich fluorescence immunoas-
say can be. The two important steps in such an assay
are the capture of analyte from solution and the binding
of fluorescently-labeled detection antibodies to the cap-
tured analyte. The capture is likely to be the limiting step
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because detection antibodies are usually provided at high
concentrations (µg mL−1). We therefore focus on the cap-
ture step as it was the case in the sections above. First, we
assume that the available volume of sample does not limit
the assay (e.g. volume >10 µL), and second, we arbi-
trarily set the duration of the capture step to 120 s for an
analyte concentration of either 1 nM or 1 pM. This dura-
tion is ∼12 times shorter than the capture time used for
experiments in which TNF-α was detected with a 1 pM
sensitivity (Cesaro-Tadic et al., 2004). To obtain a suf-
ficient signal in such a short time, the binding reaction
must be very efficient and fast, especially for low analyte
concentration where only a small fraction of the capture
sites can be bound with analytes at equilibrium. A crucial
strategy for fast assays is then to have a high flow velocity
to prevent mass transport limitations and a small feature
area to increase the analyte exploitation. Small feature ar-
eas might be achieved by orienting the capture antibody
on the surface and/or roughening the surface used for cap-
ture. Figure 8 predicts the surface density of analytes
captured on the surface for 150 and 1500 nm2 feature ar-
eas. The model suggests that generating a strong enough
signal in only 120 s is not challenging when the analyte has
a concentration of 1 nM, Figure 8(a) and (b). The density
of surface-bound analytes should in this case amount to
422 per µm2. A high flow velocity of 0.7 mm s−1 is ben-
eficial in the case of small feature areas. At 1 pM analyte
concentration, the limit of detection cannot be reached in
120 s if the feature area is 1500 nm2, Figure 8(c). A smaller
feature area is helpful to increase the surface density of
captured analytes close to the detection threshold if the
Fig. 8. Number of captured molecules per µm2 as a function of time
for an analyte concentration in (a), (b) [(c), (d)] of 1 nM [1 pM] and a
feature area in (a), (c) [(b), (d)] of 1500 nm2 [150 nm2].
flow velocity is 0.7 mm s−1, Figure 8(d). If the flow ve-
locity is further increased to 2.8 mm s−1 (data not shown),
the model predicts that an analyte concentration down to
1 pM can be measured in 120 s, yielding a surface density
of captured analytes of 0.68 µm−2.
3.6.2. Optimizing assays using minimal volumes of
analyte. For some applications, only very limited
amounts of sample analyte might be available and hav-
ing a fast assay is less important. We now investigate
what the smallest volume of analyte solution needed
to detect an analyte at a concentration of 1 pM is. In
this case, the analyte has to be exploited as much as
possible.
We learned from Figure 4(c) that an exploitation of
the analyte of >95% can be achieved by using a feature
area of 150 nm2 and a flow velocity of 0.007 mm s−1
(flow rate of 0.25 nL min−1). With this feature area and
flow velocity, the surface density of captured analytes be-
comes sufficient for detection after an incubation time
of 55 min. This translates into a consumption of only
∼13.8 nL of sample. If the feature area is 1500 nm2 and
the flow velocity is 0.007 mm s−1, the analyte exploitation
is ∼86% and the incubation to achieve sufficient signal
increases to ∼85 min. In this case, ∼21.3 nL of sample
is necessary. A higher signal might be desirable and we
therefore consider the case where the surface density of
captured analytes is 2 per µm2. The volume of analyte
needed with a 1 pM analyte concentration and a flow ve-
locity of 0.7 mm s−1 becomes ∼263 nL and the assay will
take 10.5 min. A slower flow of 0.07 mm s−1 would in-
crease the analyte exploitation and require a slightly longer
assay and much less sample: 25.5 min and ∼63.8 nL,
respectively.
3.6.3. Increasing the dynamic range of the assay.
Many biological assays have a limited dynamic range
due to the equilibrium behavior dictated by equation (5).
Saturation of the capture sites is easily reached for con-
centrations of analyte (e.g. 100 nM) that are higher than
1
K , and the surface density of captured analytes dimin-
ishes dramatically as soon as the analyte concentration
becomes smaller than 1K . Sensitive assays will be lim-
ited in dynamic range mostly by saturation at which high
analyte concentrations lead to a fast and complete cov-
erage of all binding sites, which makes it impossible to
distinguish between different elevated concentrations of
analyte. The dilution of the analyte sample that solves this
problem with assays done using microtiter plates is not
an ideal solution for a microfluidic-based immunoassay.
We suggest that flushing a solution of analyte through
an array of parallel microchannels at different flow rates
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can expand the dynamic range of the assay. Figure 6
suggested that decreasing the flow velocity from 0.7 to
0.007 mm s−1 will increase the time needed to saturate
the capture sites with a 100 nM analyte concentration
from 45 to 70 s. The freedom in designing microchan-
nels of various heights and depths in Si could be used
to implement this strategy. In our previous work, the dy-
namic range for a sandwich fluorescence immunoassay
for TNF-α was from 20 pg mL−1 to ∼50 ng mL−1, and
we suggest that the upper limit of the dynamic range
could be increased to 1 µM using the method described
here.
4. Conclusions
Microfluidic networks offer several advantages over con-
ventional microtiter plates where the assays are done using
much larger volumes. However, to take full advantage of
microfluidic networks, it is important to identify the ma-
jor parameters of assays in microfluidics as well as their
interplay. The theoretical model developed here aims at
understanding the relative importance of the transport of
analyte in a microchannel by diffusion and convection,
the binding kinetics between an analyte in solution and a
surface-immobilized antibody, and the footprint of a cap-
ture antibody on the substrate for the assay. The flow ve-
locity of the analyte solution in the microchannel is prob-
ably the parameter that is the most practical to vary using
microfluidics with capillary pumps or using forced evapo-
ration. Strategies to increase the surface density and orient
the capture antibodies can also be applied to enhance the
performances of the assays greatly. The substrate for the
assay surface could be roughened, for example, or capture
antibodies could be immobilized via their Fc part with
cross-linkers or protein A or G, or using affinity-contact
printing (Bernard et al., 2001a). Many assays would bene-
fit from using very small amounts of sample or from being
very fast. As the overall number of analyte molecules in
miniaturized assays is typically small (≤1 femtomol), it
is important to exploit analytes as much as possible. An
exciting outcome of this model is the indication that an an-
alyte could be detected with picomolar sensitivity with a
capture step of only 2 min duration using appropriately en-
gineered capture sites. Conversely, longer assays and low
flow rates might be used to perform 1 pM sensitivity assays
using a few tens of nanoliters only. The model presented
here and the experimental results obtained previously co-
incide in showing that microfluidic networks have an ex-
cellent potential to miniaturize surface immunoassays that
have demanding performances, such as in point-of-care
testing where multiple disease markers could be detected
at low concentrations in a single drop of sample and within
minutes.
Appendix: Supplementary Information
A. Implementation of the model
The model was implemented using the method de-
scribed in Griebel et al. (1995) and is divided in
two parts: the first part calculates the velocity vector
field and the second calculates the convection-diffusion-
equation and the binding kinetics to the concentration
field.
The velocity vector field is calculated using the finite








































are discretized on a regular staggered grid, Figure 9. To
prevent numerical oscillations the different variables for
velocity in the x- and y-direction, u, v, and the pressure
P are localized at diverse positions on the grid cells. The
boundary conditions are “no-slip” (u = 0) on the chan-
nel walls, “inflow” (u = const.) at the inlet and “outflow”
( ∂(u,v)dn = 0) at the channel end. Furthermore we have to
prevent stability problems occurring in discretized second-
order differential equations at convection-dominated flow
conditions. For this, a variety of different methods are de-














Fig. 9. 2D staggered grid used to model the flow by diffusion and
convection.
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(kr (ui + ui+1)
− kl(ui−1 + ui )) + 12 δx
(|kr |(ui − ui+1) − |kl |(ui−1 − ui )), (10)
which has a good stability performance and combined it


















which has a higher approximation performance than the
donor-cell scheme. Equations (10) and (11) are shown as a
one-dimensional example. They are averaged using a real
parameter γ chosen from the interval [0, 1]:
γ · Donor Cell + (1 − γ ) · Central Difference. (12)
We have to introduce another stability condition for
the time step to guaranty the stability of the numerical
algorithm. We use a time-step control which includes the
Courant-Friedrichs-Levi conditions:

















τ ∈]0, 1] . (13)
These conditions prevent volume elements of liquid from
moving further than one cell width, δx or δy, during the
time δt .
The second part of the model applies only the
convection-diffusion equation, equation (3), and the bind-
ing kinetics, equation (4), to the concentration field. These
equations have been discretized using the same models.
The boundary conditions for equation (3) are a “constant
concentration” at the inlet, “no flow” across the channel
wall, and a simple “outflow” condition. For boundary cells
next to the capture area, equation (4) is linked to equa-
tion (3) via the source term which can reduce or increase
the analyte concentration in this boundary cell depend-
ing on the saturation of the capture area and the binding
constants.
B. Validation of the implemented numerical model
Specific problems that can be described by analytical so-
lutions are compared with the simulated results. Figure 10
shows the validation of the diffusion of the analyte dur-
ing the assay. In this case, the flow velocity of the liq-
uid in the microchannel is reduced to a minimal value
to suppress convection. The mass transport then results
from diffusion. The analytical solution is given as a refer-
ence. The correlation between the numerical and the ana-
Fig. 10. Verification of the diffusion model using a slow convection in
the x-direction. The graphs show the concentration profile along the
channel after 15 and 45 s, starting from infinite source at inlet
x = 0 µm into the initially empty channel. At flow velocities
≤ 0.07 µm s−1, diffusion predominates mass transport. Convection
starts to have an effect on the transport of analyte in the microchannel
for a flow velocity of 0.7 µm s−1, and substantially contributes to the
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Fig. 11. Visualization of the self-established laminar flow profile for
(a) a short zone of flow development (at the inlet on the left-hand side)
where the boundary conditions are “constant inflow” (left), “no-slip”
(top, bottom) and “outflow” (right), and (b) for a channel having two
obstacles.
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Fig. 12. The resemblance of the flow profiles obtained with the
analytical and numerical model validates the numerical model
describing the velocity flow profile. The flow profile here occurs at a
x-position outside the flow development zone for a 50 µm deep
channel. The lines are provided as guides to the eye.
Fig. 13. Saturation of immobilized capture sites on a channel wall
segment at 1 nM analyte concentration. The binding reaction,
represented by a ligand receptor model, is not slowed down at flow
velocities of 0.7 mm s−1.
lytical solutions is excellent for the two graphs shown in
Figure 10.
The flow velocity and the parabolic profile also have an
important effect on the mass transport of analyte within
the microchannel. Figure 11 gives an example of the
capabilities of the model to describe the flow in the mi-
crochannel. Figure 12 shows the agreement between the
analytical and the numerical solution describing the self-
established flow profile.
The correctness of the ligand-receptor binding model
is shown in Figure 13. No significant analyte exploitation
occurs at high flow velocities. The curves describing the
saturation of the binding sites obtained with the numerical
and the analytical model are in agreement.
Acknowledgments
M. Z. acknowledges financial support from the Swiss
Commission for Technology and Innovation (KTI, 7039.1
TNS) and M. W. from Nanotechnology of the Swiss
National Science Foundation (NCCR). We thank H. J.
Gu¨ntherodt, G. Dernick, H. Schmid and D. Juncker for
helpful discussions.
References
L.M. Amzel and R.J. Poljak, Annu. Rev. Biochem. 48, 961–997
(1979).
F.S. Apple, R.H. Christenson, R. Valdes, A. Andriak, A. Berg, S. Duh, Y.
Feng, S.A. Jortani, N.A. Johnson, B. Koplen, K. Mascotti, and A.H.B.
Wu, Clin. Chem. 45, 199–205 (1999).
G. Balgi, D.E. Leckband, and J.M. Nitsche, Biophys. J. 68, 2251–2260
(1995).
A. Bernard, D. Fitzli, P. Sonderegger, E. Delamarche, B. Michel, H.R.
Bosshard, and H. Biebuyck, Nature Biotechnology 19, 866–869
(2001a).
A. Bernard, B. Michel, and E. Delamarche, Anal. Chem. 73, 8–12
(2001b).
S. Cesaro-Tadic, G. Dernick, D. Juncker, G. Buurman, H. Kropshofer,
B. Michel, C. Fattiger, and E. Delamarche, Lab on a Chip 4, 563–569
(2004).
E. Delamarche, in Nanobiotechnology, edited by C. Niemeyer and C.
Mirkin (Wiley-VCH Verlag, Weinheim, 2004), pp. 31–52.
D.A. Edwards, J. Appl. Math. 63, 89–112 (1999).
D.A. Edwards, B. Goldstein, and D.S. Cohen, J. Math. Biol. 39, 533–561
(1999).
R.P. Ekins, Clin. Chem. 44, 2015–2030 (1998).
Genetix, ‘aQuire microarray scanner specification sheet’. Genetix Ltd.,
http://www.genetix.com (2004).
R. Gentry, R. Martin, and B. Daly, J. Comp. Phys. 1, 87–118
(1966).
M. Griebel, T. Dornseifer, and T. Neunhoeffer, Numerische Simula-
tion in der Stro¨mungsmechanik (Vieweg, Braunschweig/Wiesbaden,
1995).
C. Hirt, B. Nichols, and N. Romero, Technical Report LA-5852, Los
Alamos Scientific Lab. (1975).
J. Jenkins, B. Prabhakarpandian, K. Lenghaus, J. Hickman, and S.
Sundaram, Anal. Biochem. 331, 207–215 (2004).
D. Juncker, H. Schmid, U. Drechsler, H. Wolf, M. Wolf, B. Michel, N.
de Rooij, and E. Delamarche, Anal. Chem. 74, 6139–6144 (2002).
W. Koenig, M. Sund, B. Filipiak, A. Do¨ring, H. Lo¨wel, and E. Ernst,
Arterioscler. Thromb. Vasc. Biol. 18, 768–772 (1998).
A. Manz and H. Becker, Microsystem Technology in Chemistry and Life
Science (Springer-Verlag, Heidelberg, 1998).
S. Metsa¨muuronen, S. Reinikainen, and M. Nystro¨m, Desalination 149,
453–458 (2002).
D.G. Myszka, X. He, M. Dembo, T.A. Morton, and B. Goldstein, Bio-
phys. J. 75, 583–594 (1998).
N.T. Nguyen and S.T. Wereley, Fundamentals and Applications of Mi-
crofluidics (Artech House, Boston, 2002).
K.L. Prime and G.M. Whitesides, Science 252, 1164–1167
(1991).
110 Zimmermann et al.
L.C. Santora, Z. Kaymkcalan, P. Sakorafas, I.S. Krull, and K. Grant,
Anal. Chem. 299, 119–129 (2001).
K.E. Sapsford, Z. Liron, Y.S. Shubin, and F.S. Ligler, Anal. Chem. 73,
5518–5524 (2001).
E.F.H. Tay (ed.), Microfluidics and BioMEMS Applications (Kluwer
Academic Publishers, Boston, 2002).
R. Vijayendran, F.S. Ligler, and D.E. Leckband, Anal. Chem. 71, 5405–
5412 (1999).
D. Wild (ed.), The Immunoassay Handbook (Nature Publishing Group,
London, 2001).
M. Wolf, D. Juncker, B. Michel, P. Hunziker, and E. Delamarche.
Biosens. Bioelectr. 19, 1193–1202 (2004).
